Quick Takeaways
- Shawn Tomasello has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $480,847.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Shawn Tomasello and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GMDA | Gamida Cell Ltd. | Director | $375,064 | 31 Jan 2024 | ||
| KLRS | Allovir, Inc. | Director | $55,461 | 06 Jun 2024 | ||
| CABA | Cabaletta Bio, Inc. | Director | $50,322 | +$50,322 | +100% | 21 Jan 2026 |
| FDMT | 4D Molecular Therapeutics, Inc. | Director | 17 Jun 2025 | |||
| TCRR | TCR2 THERAPEUTICS INC. | Director | 01 Jun 2023 | |||
| URGN | UroGen Pharma Ltd. | Director | 07 Jun 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|